SCTX · Company research
Scribe Therapeutics Inc. Common Stock (SCTX): Stock News & Events
Recent company-linked news records available in the database.
RESEARCH CONTEXT
Understand the numbers
Recent company-linked news records available in the database. Use period, currency, units and source fields when interpreting values.
13records availableHealthcare
Stock News & Events data
Database-backed records only
| title | summary | url | source | published at | sentiment | sentiment score | relevance score |
|---|---|---|---|---|---|---|---|
| Scribe Therapeutics Inc. (NASDAQ:SCTX) Sees Significant Growth in Short Interest - MarketBeat | Scribe Therapeutics Inc. (NASDAQ:SCTX) Sees Significant Growth in Short Interest MarketBeat | View source ↗ | MarketBeat | Oct 12, 2026 | neutral | 0 | 0.6 |
| Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Rated "Moderate Buy" by Wall Street Analysts - MarketBeat | Scribe Therapeutics Inc. (NASDAQ:SCTX) Stock Rated "Moderate Buy" by Wall Street Analysts MarketBeat | View source ↗ | MarketBeat | Sep 28, 2026 | neutral | 0 | 0.6 |
| Scribe Surges On IPO Debut — But All Eyes Turn To 1H27 Data (NASDAQ:SCTX) - Seeking Alpha | Scribe Surges On IPO Debut — But All Eyes Turn To 1H27 Data (NASDAQ:SCTX) Seeking Alpha | View source ↗ | Seeking Alpha | Sep 27, 2026 | neutral | 0 | 0.6 |
| Scribe Therapeutics stock coverage initiated at Goldman Sachs - Investing.com | Scribe Therapeutics stock coverage initiated at Goldman Sachs Investing.com | View source ↗ | Investing.com | Aug 18, 2026 | neutral | 0 | 0.6 |
| Should I buy Scribe Therapeutics Inc. (SCTX) - Zacks Investment Research | Should I buy Scribe Therapeutics Inc. (SCTX) Zacks Investment Research | View source ↗ | Zacks Investment Research | Aug 16, 2026 | neutral | 0 | 0.6 |
| Insider Purchase: Director at $SCTX Buys 1,000,000 Shares | SCTX Stock News - Quiver Quantitative | Insider Purchase: Director at $SCTX Buys 1,000,000 Shares | SCTX Stock News Quiver Quantitative | View source ↗ | Quiver Quantitative | Jul 29, 2026 | neutral | 0 | 0.6 |
| CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO - MedCity News | CRISPR Biotech Scribe Therapeutics Writes a New Chapter With $129M IPO MedCity News | View source ↗ | MedCity News | Jul 24, 2026 | neutral | 0 | 0.6 |
| Scribe Therapeutics Inc. (SCTX) Stock Price, News, Quote & History - Yahoo! Finance Canada | Scribe Therapeutics Inc. (SCTX) Stock Price, News, Quote & History Yahoo! Finance Canada | View source ↗ | Yahoo! Finance Canada | Jul 24, 2026 | neutral | 0 | 0.6 |
| Scribe Therapeutics (SCTX) Stock Price, News & Analysis - Stock Titan | Scribe Therapeutics (SCTX) Stock Price, News & Analysis Stock Titan | View source ↗ | Stock Titan | Jul 24, 2026 | neutral | 0 | 0.6 |
| Scribe Therapeutics Inc. (SCTX) stock price, news, quote and history - Yahoo Finance UK | Scribe Therapeutics Inc. (SCTX) stock price, news, quote and history Yahoo Finance UK | View source ↗ | Yahoo Finance UK | Jul 24, 2026 | neutral | 0 | 0.6 |
| Scribe Therapeutics (Nasdaq:SCTX) - Stock Analysis - Simply Wall Street | Scribe Therapeutics (Nasdaq:SCTX) - Stock Analysis Simply Wall Street | View source ↗ | Simply Wall Street | Jul 23, 2026 | neutral | 0 | 0.6 |
| Scribe Therapeutics Inc. Common Stock (SCTX) Historical Quotes - Nasdaq | Scribe Therapeutics Inc. Common Stock (SCTX) Historical Quotes Nasdaq | View source ↗ | Nasdaq | Jul 23, 2026 | neutral | 0 | 0.6 |
| symbol__ Stock Quote Price and Forecast - CNN | symbol__ Stock Quote Price and Forecast CNN | View source ↗ | CNN | Jul 22, 2026 | neutral | 0 | 0.6 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.